117 related articles for article (PubMed ID: 127849)
1. Letter: Clindamycin for acne.
Innes IR
JAMA; 1976 Jan; 235(3):250. PubMed ID: 127849
[No Abstract] [Full Text] [Related]
2. Letter: Clindamycin-associated colitis.
Wolfe MS
JAMA; 1974 Jul; 229(3):266-7. PubMed ID: 4275733
[No Abstract] [Full Text] [Related]
3. [Clindamycin in acne vulgaris].
Polano MK
Ned Tijdschr Geneeskd; 1976 Jul; 120(27):1165-6. PubMed ID: 132615
[No Abstract] [Full Text] [Related]
4. Letter: Lincomycin and clindamycin colitis.
Wilson DH; Cunliffe WJ; Tan SG
Br Med J; 1974 Nov; 4(5939):288-9. PubMed ID: 4279127
[No Abstract] [Full Text] [Related]
5. Colitis associated with clindamycin.
Med Lett Drugs Ther; 1974 Aug; 16(18):73-4. PubMed ID: 4277410
[No Abstract] [Full Text] [Related]
6. Potential hazards of clindamycin in acne therapy.
Basler RS
Arch Dermatol; 1976 Mar; 112(3):383-5. PubMed ID: 130836
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin therapy for moderately severe acne.
Arch Dermatol; 1976 Sep; 112(9):1323-4. PubMed ID: 136928
[No Abstract] [Full Text] [Related]
8. The unwanted effects of clindamycin in acne.
Tan SG; Cunliffe WJ
Br J Dermatol; 1976 Mar; 94(3):313-5. PubMed ID: 130162
[TBL] [Abstract][Full Text] [Related]
9. Tetracyclines for acne.
Med Lett Drugs Ther; 1975 Jun; 17(12):51-2. PubMed ID: 124010
[No Abstract] [Full Text] [Related]
10. Acne vulgaris: double-blind trial comparing tetracycline and clindamycin.
Poulos ET; Tedesco FJ
Arch Dermatol; 1976 Jul; 112(7):974-6. PubMed ID: 132902
[TBL] [Abstract][Full Text] [Related]
11. Clindamycin vs placebo as adjunctive therapy in moderately severe acne.
Christian GL; Krueger GG
Arch Dermatol; 1975 Aug; 111(8):997-1000. PubMed ID: 134670
[TBL] [Abstract][Full Text] [Related]
12. The safety of topically applied clindamycin for acne.
Fisher AA
Cutis; 1979 Apr; 23(4):406, 416-8, 522. PubMed ID: 154993
[No Abstract] [Full Text] [Related]
13. Clindamycin for tetracycline-resistant acne.
Basler RS
Cutis; 1980 May; 25(5):527-8. PubMed ID: 6445814
[TBL] [Abstract][Full Text] [Related]
14. The safety of long-term clindamycin therapy for acne.
Dantzig PI
Arch Dermatol; 1976 Jan; 112(1):53-4. PubMed ID: 129034
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
Leyden JJ; Berger RS; Dunlap FE; Ellis CN; Connolly MA; Levy SF
Am J Clin Dermatol; 2001; 2(1):33-9. PubMed ID: 11702619
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
[TBL] [Abstract][Full Text] [Related]
17. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris.
Leyden JJ; Krochmal L; Yaroshinsky A
J Am Acad Dermatol; 2006 Jan; 54(1):73-81. PubMed ID: 16384759
[TBL] [Abstract][Full Text] [Related]
18. Allergic contact dermatitis caused by clindamycin mimicking 'retinoid flare'.
Romita P; Ettorre G; Corazza M; Borghi A; Foti C
Contact Dermatitis; 2017 Sep; 77(3):181-182. PubMed ID: 28766800
[No Abstract] [Full Text] [Related]
19. Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. Introduction.
Eichenfield L
Cutis; 2009 Nov; 84(5 Suppl):3-4. PubMed ID: 19999186
[No Abstract] [Full Text] [Related]
20. Systemic absorption of topical clindamycin.
Voron DA
Arch Dermatol; 1978 May; 114(5):798. PubMed ID: 148241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
